• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number 87047
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis (2100); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 04/11/2019
Event Type  Injury  
Event Description
It was reported that the patient experienced a cardiac perforation, pericardial effusion and thrombosis.On (b)(6) 2019, an ablation procedure was performed for persistent atrial fibrillation (af).The catheters inserted were a non-boston scientific (bsc) inner fr.- braided deflectable sheath, a non-bsc trans-septal sheath, a non-bsc diagnostic catheter in right atrium, a non-bsc ice catheter in right atrium, a bsc intellanav mifi open-irrigated catheter inserted in the left atrial appendage via sl0 8.5 inner fr - braided fixed 87cm sheath and a bsc intellamap orion catheter inserted in the left atrium via the non-bsc inner fr.- braided deflectable sheath.The activated clotting time (act) was greater than 300 seconds.Irrigation flow rate was a 2cc per minute maintenance rate.No radiofrequency (rf) lesions were delivered.The non-bsc diagnostic catheter and ice catheters were placed and double transseptal access was achieved with no ice documented events.The initial left atrial 3d model began, both the orion and the intellanav catheters were actively used to create the surface.After a few minutes of mapping with the orion, the electrophysiologist (ep) was not able to cannulate the right inferior pulmonary vein (ripv) or left inferior pulmonary vein (lipv).Resistance was felt with both the ablation and orion catheters during surface creation.The physician then pulled the intellanav catheter away from the left atrial appendage (laa) and began to probe for the ostia of both the lipv and ripv.Soon after this, the patient developed a pericardial effusion requiring urgent pericardiocentesis.The patient left the room in stable condition at approximately 13:30 eastern standard time (est).As of 14:50 est, the patient was extubated, conscience and alert.The physician felt that the intellanav mifi oi ablation catheter, while in the left atrial appendage, was the most likely catheter to have caused the perforation.The patient was seen in the office by the physician on (b)(6) 2019 and was fully recovered with no health issues related to this event.
 
Event Description
It was reported that the patient experienced a cardiac perforation, pericardial effusion and thrombosis.On (b)(6) 2019, an ablation procedure was performed for persistent atrial fibrillation (af).The catheters inserted were a non-boston scientific (bsc) inner fr.Braided deflectable sheath, a non-bsc trans-septal sheath, a non-bsc diagnostic catheter in right atrium, a non-bsc ice catheter in right atrium, a bsc intellanav mifi open-irrigated catheter inserted in the left atrial appendage via sl0 8.5 inner fr braided fixed 87cm sheath and a bsc intellamap orion catheter.Catheter inserted in the left atrium via the non-bsc inner fr.Braided deflectable sheath.The activated clotting time (act) was greater than 300 seconds.Irrigation flow rate was a 2cc per minute maintenance rate.No radiofrequency (rf) lesions were delivered.The non-bsc diagnostic catheter and ice catheters were placed and double transseptal access was achieved with no ice documented events.The initial left atrial 3d model began, both the orion and the intellanav catheters were actively used to create the surface.After a few minutes of mapping with the orion, the electrophysiologist (ep) was not able to cannulate the right inferior pulmonary vein (ripv) or left inferior pulmonary vein (lipv).Resistance was felt with both the ablation and orion catheters during surface creation.The physician then pulled the intellanav catheter away from the left atrial appendage (laa) and began to probe for the ostia of both the lipv and ripv.Soon after this, the patient developed a pericardial effusion requiring urgent pericardiocentesis.The patient left the room in stable condition at approximately 13:30 eastern standard time (est).As of 14:50 est, the patient was extubated, conscience and alert.The physician felt that the intellanav mifi oi ablation catheter, while in the left atrial appendage, was the most likely catheter to have caused the perforation.The patient was seen in the office by the physician on (b)(6) 2019 and was fully recovered with no health issues related to this event.
 
Manufacturer Narrative
The device was returned for analysis.Dried body fluid was found on the handle, main shaft and distal end.Tip motion was evaluated against a curve template.Both right and left curves reached the specified template area.The steering knob and the tension control knob functioned properly on both lock and unlock positions.No abnormal resistance was felt when actuating the steering mechanism.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV MIFI OPEN-IRRIGATED
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8574035
MDR Text Key143845979
Report Number2134265-2019-04775
Device Sequence Number1
Product Code OAD
UDI-Device Identifier08714729938378
UDI-Public08714729938378
Combination Product (y/n)N
PMA/PMN Number
P150005/S017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/02/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/28/2020
Device Model Number87047
Device Catalogue Number87047
Device Lot Number0023005850
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/26/2019
Date Manufacturer Received05/31/2019
Patient Sequence Number1
Treatment
INTELLAMAP ORION CATHETER; INTELLAMAP ORION CATHETER; INTELLAMAP ORION CATHETER
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-